InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
44%
T+90 mean return
-3.5%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by STALNECKER SUSAN M, Director. Officer active across 2 companies, notably Leidos Holdings, Inc.. Aggregated, 12 disclosures have been logged. History available since 7 May 2021. The latest transaction was filed on 18 February 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
4,070 shares@ US$63.0836.6% of flowCommon StockSEC:0001628280-25-006392:0
30,400 shares0Class A Common StockSEC:0001578563-24-000271:0
912 shares0Common StockSEC:0001628280-24-021257:0
4,788 shares@ US$52.7035.1% of flowCommon StockSEC:0001628280-24-020295:0
16,648 shares0Class A Common StockSEC:0001578563-23-000043:0
5,193 shares@ US$39.7028.2% of flowCommon StockSEC:0001336920-23-000038:0
1,574 shares0Common StockSEC:0001628280-23-016984:0
1,106 shares0Common StockSEC:0001628280-22-013641:0
23,416 sharesClass A Common StockSEC:0000899243-22-013947:0
9,000 sharesClass A Common StockSEC:0000899243-22-006534:0
1,059 shares0Common StockSEC:0001628280-21-009872
1,059 shares0Common StockSEC:0001628280-21-009872:0
12 of 12 declarations
About STALNECKER SUSAN M
Susan M. Stalnecker serves as a Board Member at Leidos Holdings, Inc. and Bioventus Inc. She plays a key role in corporate governance, bringing her expertise in strategy and management. As a board member, Susan contributes to the development of policies and strategic decisions that influence the direction of the company.
